Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Morgan

Showing results (601-610 of 627) with videos related to

Pageof 63
Sort By:
Nature|October 3, 2000
A chemical switch for inhibitor-sensitive alleles of any protein kinaseA C Bishop, J A Ubersax, D T Petsch, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 1, 1997
Second Australian National Blood Pressure Study (ANBP2). Australian Comparative Outcome Trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of AustraliaL M Wing, C M Reid, P Ryan, et al.
The New England Journal of Medicine|February 14, 2003
A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderlyLindon M H Wing, Christopher M Reid, Philip Ryan, et al.
Public Health|June 15, 2010
Assessing public health risk in the London polonium-210 incident, 2006H Maguire, G Fraser, J Croft, et al.
Optics Express|August 23, 2018
InP-based quantum cascade lasers monolithically integrated onto siliconRowel Go, H Krysiak, M Fetters, et al.
American Journal of Hypertension|June 1, 2005
Predictors of failure to initiate randomized treatment in a large trial of antihypertensive drug therapy in the agedMark R Nelson, Philip Ryan, Kristyn Willson, et al.
The West Indian Medical Journal|July 9, 2009
Evolving care of HIV-infected pregnant women in Jamaica--from nevirapine to HAARTN Johnson, P Palmer, L A Samuels, et al.
Cancer Biology & Therapy|November 12, 2019
Botryllamide G is an ABCG2 inhibitor that improves lapatinib delivery in mouse brainJonathan D Strope, Cody J Peer, Tristan M Sissung, et al.
Scientific Reports|February 23, 2012
Phosphorylation of CRN2 by CK2 regulates F-actin and Arp2/3 interaction and inhibits cell migrationCharles-Peter Xavier, Raphael H Rastetter, Margit Blömacher, et al.
Clinical and Experimental Pharmacology & Physiology|May 1, 1997
Feasibility of conducting cardiovascular outcome research in Australian general practice: results from the ANBP2 pilot study. Australian National Blood Pressure StudyC M Reid, M Nelson, P Beckinsale, et al.
Pageof 63

Showing results (601-610 of 627) with videos related to

Sort By:
Pageof 63
Nature|October 3, 2000
A chemical switch for inhibitor-sensitive alleles of any protein kinaseA C Bishop, J A Ubersax, D T Petsch, et al.
Clinical and Experimental Hypertension (New York, N.Y. : 1993)|July 1, 1997
Second Australian National Blood Pressure Study (ANBP2). Australian Comparative Outcome Trial of ACE inhibitor- and diuretic-based treatment of hypertension in the elderly. Management Committee on behalf of the High Blood Pressure Research Council of AustraliaL M Wing, C M Reid, P Ryan, et al.
The New England Journal of Medicine|February 14, 2003
A comparison of outcomes with angiotensin-converting--enzyme inhibitors and diuretics for hypertension in the elderlyLindon M H Wing, Christopher M Reid, Philip Ryan, et al.
Public Health|June 15, 2010
Assessing public health risk in the London polonium-210 incident, 2006H Maguire, G Fraser, J Croft, et al.
Optics Express|August 23, 2018
InP-based quantum cascade lasers monolithically integrated onto siliconRowel Go, H Krysiak, M Fetters, et al.
American Journal of Hypertension|June 1, 2005
Predictors of failure to initiate randomized treatment in a large trial of antihypertensive drug therapy in the agedMark R Nelson, Philip Ryan, Kristyn Willson, et al.
The West Indian Medical Journal|July 9, 2009
Evolving care of HIV-infected pregnant women in Jamaica--from nevirapine to HAARTN Johnson, P Palmer, L A Samuels, et al.
Cancer Biology & Therapy|November 12, 2019
Botryllamide G is an ABCG2 inhibitor that improves lapatinib delivery in mouse brainJonathan D Strope, Cody J Peer, Tristan M Sissung, et al.
Scientific Reports|February 23, 2012
Phosphorylation of CRN2 by CK2 regulates F-actin and Arp2/3 interaction and inhibits cell migrationCharles-Peter Xavier, Raphael H Rastetter, Margit Blömacher, et al.
Clinical and Experimental Pharmacology & Physiology|May 1, 1997
Feasibility of conducting cardiovascular outcome research in Australian general practice: results from the ANBP2 pilot study. Australian National Blood Pressure StudyC M Reid, M Nelson, P Beckinsale, et al.
Pageof 63